All coverage
AstraZeneca shares drop after company announces 'routine' safety pause in coronavirus vaccine trial
By Berkeley Lovelace & Berkeley Lovelace Jr.
Halting the Oxford vaccine trial doesn't mean it's not safe – it shows they're following the right process
By Jim Buttery & Nigel W Crawford
Oxford Vaccine: AstraZeneca Pauses Trial After Unexplained Illness
By Michelle Cortez & Riley Griffin
Oxford University Covid vaccine trial put on hold due to possible adverse reaction in participant
By Elias Visontay
Safety Review Begins Into AstraZeneca's Coronavirus Vaccine Trial
By Katherine J. Wu
Oxford vaccine trial on hold because of potential safety issue
By Erika Edwards & Sara G. Miller
AstraZeneca Pauses Vaccine Trial for Safety Review
By Katie Thomas & Katherine J. Wu